Publication:
Targeting `Undruggable' Cancer Proteins with Irreversible Small Molecule Inhibitors: Her3 and KRas

Thumbnail Image

Date

2014-06-06

Authors

Published Version

Published Version

Journal Title

Journal ISSN

Volume Title

Publisher

The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Xie, Ting. 2014. Targeting `Undruggable' Cancer Proteins with Irreversible Small Molecule Inhibitors: Her3 and KRas. Doctoral dissertation, Harvard University.

Research Data

Abstract

With the lighting speed revolution of technologies in chemistry and biology, increasing number of proteins which eluded scientists' efforts to block them before and were labeled as `undruggable', were successfully targeted with small molecule inhibitors. During the past five years, I have been working on figuring out the path to inhibit two elusive cancer targets: Her3 and KRas.

Description

Other Available Sources

Keywords

Chemistry, Biology, Biochemistry, Her3, KRas

Terms of Use

Metadata Only

Endorsement

Review

Supplemented By

Referenced By

Related Stories